Worst case, it sucks......and a very good buying opportunity, it's uses a self learning algorithm which has improved accuracy in the past during the clinical trials in Australia and they seemingly have the cash on hand for 1+ year expenditure.
RAP Price at posting:
31.0¢ Sentiment: Buy Disclosure: Held